Endothelin-1 (ET-1) and oxidative stress are involved in the development of hypertension-induced cardiovascular complications. The aim of this study was to evaluate the relationship between plasma ET-1 level and plasma antioxidant capacity and carotid atherosclerosis. In 61 treated patients with hypertension (44 women, 35 diabetics, mean age 72.4 ± 7.2 years) medical histories, ambulatory blood pressure, blood tests (glucose, creatinine, cholesterol, haemoglobin A1c (HbA1c), ET-1) and common carotid artery intima-media thickness (CCA-IMT) measurement were carried out. Plasma antioxidant capacity was assessed by the ferric-reducing ability of plasma (FRAP). Subjects with diabetes presented with higher concentrations of glucose (7.01 ± 2.3 vs 5.14±0.6 mmol l À1 , Po0.001), HbA1c (7.75±2.1 vs 6.1±1.2%, Po0.001) and ET-1 (1.36±0.53 vs 1.01± 0.4 pg ml À1 , Po0.01), and lower cholesterol level (5.02±0.8 vs 5.86±1.3 mmol l À1 , Po0.01). A significant positive correlation between CCA-IMT and ET-1 plasma concentration (r ¼ 0.40, Po0.001) and reverse relationship between CCA-IMT and FRAP (r ¼ À0.36, Po0.01) was observed. In a stepwise regression analysis, after adjustment for all confounders, CCA-IMT was independently influenced by age, systolic blood pressure (SBP), HbA1c and ET-1. When FRAP was included in the regression model, CCA-IMT was significantly influenced by age, FRAP, HbA1c and SBP. ET-1 promotes the increase in CCA-IMT contributing to the development of end-organ damage. Plasma antioxidant capacity may modulate this deleterious effect, but whether better antioxidant defence may prevent against the development of atherosclerosis remains to be elucidated.
Introduction
Endothelin-1 (ET-1), the predominant isoform of the ET peptide family has potent vasoconstrictor, mitogenic and proinflammatory properties. 1 Endogenous ET-1 has a physiological role in the control of vascular tone and blood pressure and functions through the vascular smooth muscle cell (VSMC) and endothelial ET A and ET B receptors. 2 The overall cardiovascular effect of ET-1 depends on the balance between ET A receptor-and ET B receptor-mediated effects, although it is suggested that ET-1 finally increases both the vascular tone and the blood pressure level. 1 Endothelial dysfunction is characterized by an imbalance between endotheliumderived contracting factors, including ET-1, angiotensin II and prostaglandin endoperoxides, and endothelium-derived relaxing factors-nitric oxide, prostacyclin (PGI 2 ) and endothelium-derived hyperpolarizing factor, comprising potassium ions, epoxyeicosatrienoic acid, C-type natriuretic peptide, hydrogen peroxide (H 2 O 2 )-responsible for nitric oxide-independent VSCM hyperpolarization and vasorelaxation. [3] [4] [5] The presence of endothelial dysfunction was confirmed in ageing and in number of diseases, including hypertension, hypercholesterolemia, diabetes, renal failure and congestive heart failure. [3] [4] [5] As a potent mitogen for glomerular mesangial cells and VSMCs, ET-1 promotes cell growth, migration and proliferation. 1, 4, 6 Through the activation of mitogen-activated protein kinase, it stimulates cardiomyocyte hypertrophy. 7, 8 Taken together, these findings suggest that ET-1 has a substantial role in the development of atherosclerosis and endorgan damage in patients with hypertension and diabetes. 4, 6 The contribution of endogenous ET-1 to cardiovascular regulation and pathogenesis and disease progression has been confirmed by the effects of ET receptor antagonists. Long-term administration of an ET A receptor antagonist decreased arterial pressure, normalized endothelial dysfunction in hypertension, ameliorated glomerulosclerosis and vascular and cardiac hypertrophy, independently of blood pressure decrease. 4, 9 It also improved endothelium-dependent relaxation and inhibited vascular lesion formation in humans and in animal models of atherosclerosis. 10, 11 It has been documented that ET-1 is involved in the interplay between oxidative stress and the development of hypertension-and diabetes-induced cardiovascular complications. 12, 13 Reactive oxygen species increase ET-1 production in endothelial and VSMCs, 14, 15 and on the other hand, they function as intracellular messengers modulating the ET-1 signalling pathway. 12, 16 As we have shown recently in hypertensive and diabetic patients, higher plasma ET-1 level is independently associated with lower plasma antioxidant capacity (assessed by ferricreducing ability of plasma-FRAP) and decreased vitamin C concentration, which may be a result of increased oxidative stress in these diseases. 17 The aim of this study was to evaluate the relationship between plasma ET-1 level and plasma antioxidant capacity, as well as the thickness of common carotid artery intima-media thickness (CCA-IMT) and the presence of atherosclerotic plaque in CCA or in the bulb in elderly patients treated for hypertension.
Methods
The study population consisted of hypertensive individuals older than 60 years of age treated at our department. Consecutively admitted hypertensive patients were eligible for this analysis if they had expressed their consent to participate in the additional examination with the understanding that part of the data might be anonymously used for scientific purposes. In all subjects, information regarding past medical history and used medication were obtained as a part of routine workup. This also included anthropometric measurements, ambulatory blood pressure monitoring using the Spacelab 90207 device (SpaceLab Inc., Redmont, WA, USA) and blood tests. In the analysis, averages of systolic blood pressure (SBP) and diastolic blood pressure values were used. Body mass index was calculated as body mass in kilograms (kg) divided by the square of height in metres (m 2 ). A patient was considered diabetic if anti-diabetic treatment was used, fasting glucose exceeded 7.0 mmol l À1 or haemoglobin A1c (HbA1c) was 47%.
Ultrasonography of carotid arteries
CCAs were assessed using B-mode ultrasonography performed with an ultrasound scanner (Vivid 3, General Electric; Israel) equipped with a 10-MHz linear probe. CCAs and their bifurcations were viewed bilaterally in their longitudinal dimension, in anterior oblique or lateral projection, in a patient in the supine position, with his/her head turned B451 to the contralateral side from the sagittal plane. Frozen frame images were archived and analysed offline manually using the Image Pro Plus 4.5 program (Media Cybernetics). The average IMT value (CCA-IMT) was calculated for the four IMT values measured at the near and far walls of the CCA proximal to its bifurcation, bilaterally. An IMT value 41.2 mm was considered diagnostic and a positive inclusion criterion for the presence of plaque.
Analytical determinations
Venous blood samples were collected after a 12-h overnight fast. Plasma glucose, creatinine and cholesterol concentrations were assayed using routine methods. HbA1c was measured using highperformance liquid chromatography.
For ET-1 determination, blood was collected into tubes containing K 3 EDTA, and centrifuged at 4 1C for 10 min. Plasma was separated and kept at À70 1C until analysis. ET-1 concentration was assessed using enzyme-linked immunosorbent assay with Parameter (R&D System Inc., Minneapolis, MN, USA).
The FRAP value (constituted by uric acid: 60% of contribution; vitamin C: 15%; a-tocopherol: 5%; bilirubin: 5%; albumin: 10%) as a method of assessment of total antioxidant capacity of plasma was measured using the spectrophotometric method described by Benzie and Strain. 18 In this study, eGFR (estimated glomerular filtration rate) was estimated according to the CockcroftGault formula (eGFR ¼ (140-age (years)) Â body weight (kg)/0.814 Â plasma creatinine (mmol l À1 ). The resulting value was multiplied by a constant of 0.85 if the patient was female. 19 
Statistical analysis
Statistical analyses were carried out using Statistica for Windows version 8.0. Results are presented as means ± s.d. or percentages. Means were compared using Student's t-test or Mann-Whitney U-test if the distribution of variables was non-normal. The relationship between ET-1 level and CCA-IMT, and similarly that between FRAP and CCA-IMT were assessed using Spearman's correlation test. The number of subjects with diabetes, and those with atherosclerotic plaque in the carotid artery was compared in the thirds of the plasma ET-1 concentration.
Furthermore, to test the independence of the influence of ET-1 or FRAP on CCA-IMT, linear regression models--with multivariate adjustment for sex, age, body mass index, smoking habits, presence of diabetes, SBP, diastolic blood pressure, plasma cholesterol, HbA1c, FRAP level and treatment with angiotensin-converting enzyme inhibitors, b-blockers and calcium channels blockers (with stepwise selection of variables)--were used. P-values o0.05 were considered statistically significant.
Results

Group characteristics
The studied group comprised 61 treated hypertensive patients, 44 women in their postmenopausal stage and 17 men, aged 60-92 years. The average age was 72.4 ± 7.2 years, and characteristics by gender are given in Tables 1 and 2 . There were no sex differences in the studied variables; therefore, for the reminder of the analysis, data for men and women were pooled and where applicable, adjusted for sex. None of the women used hormone replacement therapy.
Hypertensive subjects with diabetes (35 individuals) had higher concentration of glucose (7.01 ± 2.3 vs 5.14 ± 0.6 mmol l À1 , Po0.001), HbA1c (7.75 ± 2.1 vs 6.1 ± 1.2%, Po0.001) and ET-1 (1.36±0.53 vs 1.01±0.4 pg ml À1 , Po0.01), and lower cholesterol level (5.02±0.8 vs 5.86± 1.3 mmol l À1 , Po0.01).
Plasma ET-1 level, plasma antioxidant capacity and CCA-IMT To analyse the relationship between plasma ET-1 concentration and CCA-IMT, we used Spearman's correlation analysis and found a linear increase in IMT with higher levels of ET-1 (r ¼ 0.40, P ¼ 0.001) (Figure 1 ). Contrary to the relation to ET-1, the negative correlation between the concentration of ET-1 in plasma and FRAP was observed, r ¼ À0.36, P ¼ 0.004 (Figure 2 ).
Plasma ET-1 and carotid atherosclerosis Subjects were divided according to the plasma ET-1 concentration to the thirds. In the second and third tertiles of ET-1 concentrations, the number of subjects with diabetes and those with atherosclerotic plaque in the carotid artery was significantly higher (Table 3) .
Multivariate regression analysis
To determine the independent influence of ET-1 on CCA-IMT thickness, a multiple regression model with CCA-IMT as a dependent variable, and age, gender, smoking habits, presence of diabetes, body mass index, SBP, diastolic blood pressure, plasma cholesterol, HbA1c level and taking angiotensinconverting enzyme inhibitors, b-blockers, calcium channels blockers as independent variables, with stepwise selection of variables, was used. In addition, a similar model but with FRAP added as an independent variable was used.
In a stepwise regression analysis without including FRAP, after adjustment for all previously described confounders, age (b ¼ 0.362, P ¼ 0. 
Discussion
In our group of treated hypertensive patients, we found increasing CCA-IMT along with higher ET-1 plasma concentration and reverse relationship of this parameter with FRAP-lower CCA-IMT along with higher FRAP level was observed. In multiple regression analysis, ET-1 level appeared as a factor independently contributing to IMT in the case when plasma antioxidant capacity was not included. These findings are in agreement with previous observations. The positive correlation between plasma ET-1 level and CCA-IMT was shown in hypertensive teenagers free from other diseases 20 and in young, normal-weight, non-dyslipidaemic, non-hypertensive women with polycystic ovary Carotid atherosclerosis and antioxidants AB Skalska and T Grodzicki syndrome-a disease characterized by increased plasma ET-1 level. 19 Plasma ET-1 concentration has been also the main associate of the change in CCA-IMT during a 30-month observation period of diabetic non-hypertensive subjects. 22 The highest concentration of ET-1 was found in diabetics with the highest CCA-IMT and with macroangiopathy. 22, 23 Moreover, atherosclerotic plaques were found more often in patients with higher ET-1 concentration. 24 It was confirmed in our study, that subjects in the higher ET-1 tertiles were more likely to have atherosclerotic plaques in the carotid artery than were those in the lower ET-1 tertiles. These clinical observations indicating that ET-1 promotes atherosclerosis are supported by immunohistochemical investigation, in which ET-1 labelling was much more intensive in atherosclerotic plaque than in medial VSMC layer in healthy subjects. 25 The relationship between ET-1 and IMT can be elucidated by the mitogenic properties of ET. Through excessive oxidative stress and activation of mitogen-activated protein kinase, tyrosine kinase pathways and nuclear factor kB, ET-1 stimulates VSMC proliferation and inflammation, all implicated in the thickening of vascular wall, vascular remodelling and in the development of atherosclerosis and end-organ damage. 8, 26 As we have shown recently, there exists an inverse correlation between plasma ET-1 level and FRAP in treated hypertensive subjects. 17 In this study, we developed this observation, and demonstrated that inclusion of FRAP in the multivariate regression model as one of the independent variables changed the relationship between ET-1 and CCA-IMT, and not ET-1, but FRAP, apart from age, SBP and HbA1c level independently inversely influenced CCA-IMT. This phenomenon may reflect the protective role of FRAP against deleterious effects of free radicals and ET-1 on the vascular wall. It is in agreement with the results of experimental studies showing that ET-1 stimulates protein synthesis and VSMC proliferation through redoxsensitive reactions. ET-1 increases oxidative stress through the activation of NAD(P)H oxidase-a key enzymatic source for superoxide anion in the vascular wall. 12, 13, 16, 27 Excessive oxidative stress activates several redox-sensitive signalling pathways resulted in activation of MAP kinase family, tyrosine kinases, transcription factors nuclear factor kB, activator protein-1, vascular cellular adhesion molecule-1 and increase release of proinflammatory cytokines. 8, 13, 26, 28, 29 The contribution of ET-1, NAD(P)H oxidase and reactive oxygen species in VSMC proliferation was confirmed by the possibility of blocking this process by pre-incubation of VSMC with ET A receptor antagonist, 13 NAD(P)H oxidase inhibitor 12, 16 or with antioxidants; 12, 13, 16 however, it was documented for extracellular superoxide dismutase, 13 and among the antioxidants included in FRAP for ascorbic acid. 12, 16 It was also shown that vitamin C inhibited activation of mitogen-activated protein kinase and VSMC proliferation in cultured rat aortic smooth muscle cells, 26 and in an in vivo experiment it was demonstrated that vitamin C supplementation decreased activation of NADPH oxidase and superoxide anion generation, prevented vascular hypertrophy and increased plasma total antioxidant status and superoxide dismutase in arterial wall in stroke-prone spontaneously hypertensive rats. 30 Vitamin C also abolished ET-1-induced increased interleukin-6 release in humans. 28 Taken together, these data and our findings suggest that arterial wall hypertrophy is a redoxsensitive process and that plasma antioxidants may prevent the deleterious effect of the ET-1-induced pathway leading to IMT and progression of atherosclerosis.
The importance of serum level of uric acid is underlined by its ability to act either as antioxidant or prooxidant 31 and thus cardiovascular risk factor, 32 which reflects its contextual mode of action, largely depending on interaction with other components of antioxidative system, the latter accounting for up to 40% of antioxidative protection. Arterial hypertension is an established risk factor for the development of atherosclerosis even in the elderly population. 33 It is also apparent in our study that SBP is an independent factor influencing CCA-IMT in a multivariate analysis. In light of the result obtained from the study by Rodrigo et al., 34 who have recently shown an inverse relationship between SBP and diastolic blood pressure and antioxidants, including FRAP in hypertensive subjects, (in our study, the correlation coefficient between SBP and FRAP ¼ À0.35, P ¼ 0.005; data not shown), it may be postulated that better antioxidant defence also through decreasing blood pressure levels prevents thickening of the arterial wall.
To date, only the relationship between antioxidant vitamins or carotenoids and carotid atherosclerosis were studied. [35] [36] [37] [38] Some of these studies estimated an association not with the plasma level but with vitamin dietary intake, 37 and their results are inconsistent. In the Perth CUDAS (Carotid Ultrasound Disease Assessment Study), after adjustment for age and conventional risk factors, a progressive decrease in mean CCA-IMT with increasing quartiles of dietary vitamin E intake in men and inverse association between CCA-IMT and plasma lycopen were found. 35 Higher plasma vitamin C and b- Abbreviation: ET-1 endothelin-1.
carotene concentrations were associated with smaller CCA-IMT in the elderly population. 36 In the ARIC (Atherosclerosis Risk In Communities) Study, CCA-IMT was inversely related to dietary vitamin C intake in men and women, and was inversely related to atocopherol intake in women, only in subjects more than 55 years of age. 37 Independent inverse associations between erythrocyte vitamin E and CCA-IMT in men and women, as well as a trend between plasma carotenoid concentration and carotid atherosclerosis were observed in the EVA (Etude sur le Vieillisement Arteriel) Study, but no association between the prevalence of plaques and either vitamin E or carotenoids was found. 38 Moreover, in the recent study by Riccioni et al., 39 CCA-IMT of 40.8 mm was associated significantly with low plasma concentration of vitamin A, E, lycopen and b-carotene. In turn, extracellular ZnCu-superoxide dismutase may protect children and adolescents with type I diabetes against endothelial dysfunction, although the differences in CCA-IMT were not found. 40 In conclusion, ET-1 promotes increase in CCA-IMT contributing to the development of end-organ damage, but at least with reference to carotid localization, plasma antioxidant capacity may modulate its deleterious effect. Whether better antioxidant defence may prevent against the development of atherosclerosis remains to be elucidated.
